RNA fusion transcript panel identifies diverse repertoire of fusions in adult glioma patients with therapeutic implications.

ABSTRACT:

Background

Recurrent gliomas are therapeutically challenging diseases with few treatment options available. One area of potential therapeutic vulnerability is the presence of targetable oncogenic fusion proteins.

Methods

To better understand the clinical benefit of routinely testing for fusion proteins in adult glioma patients, we performed a retrospective review of 647 adult patients with glioma who underwent surgical resection at our center between August 2017 and May 2021 and whose tumors were analyzed with an in-house fusion transcript panel.

Results

Fifty-two patients (8%) were found to harbor a potentially targetable fusion with 11 (21%) of these patients receiving treatment with a fusion-targeted inhibitor. The targetable genes found to be involved in a fusion

SUBMITTER: Kothari S 

PROVIDER: S-EPMC10346416 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature